Thomas F. Gajewski
Plus aucun poste en cours
Profil
Thomas F.
Gajewski is the founder of Jounce Therapeutics, Inc. (founded in 2013).
Dr. Gajewski is also the founder of Pyxis Oncology, Inc. He received his undergraduate and doctorate degrees from The University of Chicago.
Anciens postes connus de Thomas F. Gajewski
| Sociétés | Poste | Fin |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Fondateur | - |
| JOUNCE THERAPEUTICS, INC. | Fondateur | - |
Formation de Thomas F. Gajewski
| The University of Chicago | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
